CN Patent

CN111481506A — 一种包含经鼻给药的右美托咪定组合物的药物制品

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2020-08-04 · 6y expired

What this patent protects

本发明涉及一种包含经鼻给药的右美托咪定组合物的药物制品。具体而言，本发明涉及一种药物制品，其包含经鼻给药的右美托咪定药物组合物及装置，该制品稳定性优异。

USPTO Abstract

本发明涉及一种包含经鼻给药的右美托咪定组合物的药物制品。具体而言，本发明涉及一种药物制品，其包含经鼻给药的右美托咪定药物组合物及装置，该制品稳定性优异。

Drugs covered by this patent

chembl-chembl2106195 (DEXMEDETOMIDINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN111481506A
Jurisdiction: CN
Classification: —
Expires: 2020-08-04
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hengrui Medicine Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.